CordenPharma | IC-Investors

HOME ⤏ WHO WE ARE ⤏ CORDENPHARMA

Full-Service CDMO Partner

Formed in 2006 as the pharmaceutical brand of ICIG
Full-Service CDMO organized in 4 distinctive platforms with specialized characteristics
Marketing & Sales provided by CordenPharma International for separately managed operating companies (legal and financial independence)

8 GMP production facilities in Europe and the United States
€ 390 million total sales
1,530 employees

Key Technologies
Drug Substance

Small Molecule Intermediates & APIs
Excipients
Peptides
Lipids
Carbohydrates
Conjugates
Highly Potent API’s
Oncology API’s
Sterile API’s

Key Technologies
Drug Product

Injectables (Vials, Ampoules, Pre-filled Syringes)
Sterile Emulsion Technology
Oral Solid Dosage Forms
Coated & Uncoated Tablets
Hard Gelatine Capsules
Sterile Liquid & Lyophilisation (Vials & Ampules)
Primary & Secondary Packaging
Blister & Bottle Packaging
Serialisation & 2D Data Matrix Coding
Clinical Trial Services